Temporal and Dose-response Effects of Nicotinamide Riboside Supplementation on Metabolic Flexibility During Zone 2 Training in Adults: a Double-blinded, Randomized, Controlled, Crossover Trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 16
- 试验地点
- 1
- 主要终点
- Substrate utilization (CHO and fat oxidation rate)
研究概览
简要总结
Zone 2 training, a low-intensity endurance exercise performed at approximately 66-80% of VO₂max or near the first ventilatory threshold, has gained popularity for improving aerobic capacity, fat metabolism, and mitochondrial efficiency. It preserves glycogen stores and delays fatigue, making it an essential training method for both athletes and recreational exercisers. Nicotinamide adenine dinucleotide (NAD) is a vital metabolite that regulates cellular energy metabolism and redox homeostasis. It participates in oxidative reactions within the tricarboxylic acid cycle and electron transport chain, sustaining ATP synthesis and mitochondrial efficiency. Exercise influences multiple pathways of NAD metabolism, altering the NAD⁺/NADH ratio and thereby affecting energy production and fatigue resistance. Studies have shown that both aerobic exercise and NAD precursor supplementation (e.g., nicotinamide riboside [NR]) can elevate body NAD levels and enhance mitochondrial function, though findings remain inconsistent due to variations in dosage and participants' characteristics. This study aims to investigate how acute NR supplementation interacts with Zone 2 cycling training in adults. Specifically, it examines the temporal and dose-dependent effects of NR supplementation on metabolic flexibility and exercise performance. The results may clarify the potential synergistic benefits of combining NAD supplementation with low-intensity endurance training to improve aerobic adaptability.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Over 18 years old
- •BMI <30 kg/m2
排除标准
- •Present of health conditions that contraindicate participation in exercise training, such as a history of cardiovascular disease, cancer, or musculoskeletal disorders
- •Currently taking vitamin B supplements and/or NAD precursors
- •Taking medication that may affect the test results
研究组 & 干预措施
600 mg
干预措施: Nicotinamide Riboside (NR) (Dietary Supplement)
300 mg
干预措施: Nicotinamide Riboside (NR) (Dietary Supplement)
0 mg
结局指标
主要结局
Substrate utilization (CHO and fat oxidation rate)
时间窗: From enrollment to the end of treatment at 4 weeks
次要结局
- Oxygen consumption(From enrollment to the end of treatment at 4 weeks)
- Heart rate(From enrollment to the end of treatment at 4 weeks)
- Blood glucose concentration(From enrollment to the end of treatment at 4 weeks)
- Blood lactate concentration(From enrollment to the end of treatment at 4 weeks)
- Peak power output(From enrollment to the end of treatment at 4 weeks)
- Mean power output(From enrollment to the end of treatment at 4 weeks)
- Rating of perceived exertion(From enrollment to the end of treatment at 4 weeks)
- Muscle pain scale(From enrollment to the end of treatment at 4 weeks)
- Muscle fatigue scale(From enrollment to the end of treatment at 4 weeks)
研究者
ZHANG Jiaqi
Principal Investigator
Chinese University of Hong Kong
